This application claims the benefit of Australian Provisional Patent Application No. 2018904012 filed 23 Oct. 2018, which is incorporated herein by reference.
The present invention relates to measurement of compound action potentials evoked by a neurostimulator, and in particular to the minimisation of artefact caused by application of an electrical stimulus.
There are a range of situations in which it is desirable to apply neural stimuli in order to give rise to a compound action potential (CAP). For example, neuromodulation is used to treat a variety of disorders including chronic pain, Parkinson's disease, and migraine. A neuromodulation system applies an electrical pulse to tissue in order to generate a therapeutic effect. When used to relieve chronic pain, the electrical pulse is applied to the dorsal column (DC) of the spinal cord, referred to as spinal cord stimulation (SCS). Neuromodulation systems typically comprise an implanted electrical pulse generator, and a power source such as a battery that may be rechargeable by transcutaneous inductive transfer. An electrode array is connected to the pulse generator, and is positioned in the dorsal epidural space above the dorsal column. An electrical pulse applied to the dorsal column by an electrode causes the depolarisation of neurons, and generation of propagating action potentials. The fibres being stimulated in this way inhibit the transmission of pain from that segment in the spinal cord to the brain. To sustain the pain relief effects, stimuli are applied substantially continuously, for example at a frequency in the range of 50-100 Hz.
Neuromodulation may also be used to stimulate efferent fibres, for example to induce motor functions. In general, the electrical stimulus generated in a neuromodulation system triggers a neural action potential which then has either an inhibitory or excitatory effect. Inhibitory effects can be used to modulate an undesired process such as the transmission of pain, or to cause a desired effect such as the contraction of a muscle.
There are a range of circumstances in which it is desirable to obtain an electrical measurement of a compound action potential (CAP) evoked on a neural pathway by an electrical stimulus applied to the neural pathway. However, this can be a difficult task as an observed CAP signal will typically have a maximum amplitude of a few tens of microvolts or less, whereas a stimulus applied to evoke the CAP is typically several volts. Electrode artefact usually results from the stimulus, and manifests as a decaying output of several millivolts or hundreds of microvolts throughout the time that the CAP occurs, presenting a significant obstacle to isolating the much smaller CAP of interest. As the neural response can be contemporaneous with the stimulus and/or the stimulus artefact, CAP measurements present a difficult challenge of implant design. In practice, many non-ideal aspects of a circuit lead to artefact, and as these mostly have a decaying exponential characteristic which can be of either positive or negative polarity, identification and elimination of sources of artefact can be laborious. A number of approaches have been proposed for recording a CAP, including those of King (U.S. Pat. No. 5,913,882), Nygard (U.S. Pat. No. 5,785,651), Daly (US Patent Application No. 2007/0225767) and the present Applicant (U.S. Pat. No. 9,386,934).
Evoked responses are less difficult to detect when they appear later in time than the artefact, or when the signal-to-noise ratio is sufficiently high. The artefact is often restricted to a time of 1-2 ms after the stimulus and so, provided the neural response is detected after this time window, data can be obtained. This is the case in surgical monitoring where there are large distances between the stimulating and recording electrodes so that the neural response propagation time from the stimulus site to the recording electrodes exceeds 2 ms. However, to characterize responses evoked by a single implant such as responses from the dorsal columns to SCS, for example, high stimulation currents and close proximity between electrodes are required, and therefore the measurement process must overcome contemporaneous artefact directly, greatly exacerbating the difficulty of neural measurement.
Similar considerations can arise in deep brain stimulation where it can be desirable to stimulate a neural structure and immediately measure the evoked compound action potential produced in that structure before the neural response propagates elsewhere in the brain. Artefact remains a significant obstacle to measurement of neural responses proximal to the stimulus location, with the consequence that most if not all conventional neurostimulation implants, which are necessarily compact devices, do not take any measurements whatsoever of neural responses evoked by the implant's stimuli.
Any discussion of documents, acts, materials, devices, articles or the like which has been included in the present specification is solely for the purpose of providing a context for the present invention. It is not to be taken as an admission that any or all of these matters form part of the prior art base or were common general knowledge in the field relevant to the present invention as it existed before the priority date of each claim of this application.
Throughout this specification the word “comprise”, or variations such as “comprises” or “comprising”, will be understood to imply the inclusion of a stated element, integer or step, or group of elements, integers or steps, but not the exclusion of any other element, integer or step, or group of elements, integers or steps.
In this specification, a statement that an element may be “at least one of” a list of options is to be understood that the element may be any one of the listed options, or may be any combination of two or more of the listed options.
According to a first aspect the present invention provides a neurostimulation device comprising:
at least one stimulation electrode configured to deliver an electrical stimulus to neural tissue; and
at least one measurement electrode configured to record a response of the neural tissue to the stimulus,
wherein the stimulus and a position of the measurement electrode relative to the stimulus electrode are configured such that, in artefact as arising relative to distance from the stimulus electrode, a minima region of the artefact is substantially co-located with the measurement electrode.
According to a second aspect the present invention provides a method of neurostimulation, the method comprising:
delivering an electrical stimulus to neural tissue using at least one stimulation electrode; and
recording a response of the neural tissue to the stimulus using at least one measurement electrode,
wherein the stimulus and a position of the measurement electrode relative to the stimulus electrode are configured such that, in artefact as arising relative to distance from the stimulus electrode, a minima region of the artefact is substantially co-located with the measurement electrode.
The minima region of artefact is defined as a spatial region in which a magnitude of artefact is reduced relative to peak artefact in spatial regions more distal from the stimulation electrode. In some embodiments, the minima region of artefact may comprise a zero crossing region of artefact, being a spatial region in which a magnitude of artefact is reduced relative to peak artefact in spatial regions more distal from the stimulation electrode, and wherein the zero crossing region of artefact contains a zero crossing of artefact. For example, in some embodiments the minima region of artefact may comprise a spatial region in which a magnitude of artefact is less than 75%, more preferably less than 50%, more preferably less than 25%, of a peak artefact arising in spatial regions more distal from the stimulation electrode. Notably, by co-locating the minima region of artefact with the measurement electrode, allows the measurement electrode to be positioned closer to the stimulation site and to thus capture a stronger and less dispersed evoked compound action potential (ECAP), while suffering from less artefact than would occur at even some locations which are further from the stimulation site. In preferred embodiments the stimulus, and a position of the measurement electrode relative to the stimulus electrode, are configured such that a minima of artefact such as the zero crossing of artefact is substantially, or preferably is precisely, co-located with the measurement electrode, so that the measurement electrode experiences negligible artefact relative to peak artefact arising at other distances from the stimulus electrode.
To this end, in at least some embodiments the present invention provides techniques relating to the design of stimulation patterns for spinal cord stimulation and other neuromodulation methods, and provides a set of methods that may be used to reduce or null artefact, thus improving measurement of tissue responses to stimulation such as a neural compound action potential evoked by the applied stimulus.
In some embodiments of the first aspect of the invention, the stimulus is configured so that the minima region of the artefact is substantially co-located with the measurement electrode, by delivering the stimulus in a multipolar fashion utilising more than two stimulus electrodes, and imposing a mismatch on the respective pairs of stimulation electrodes in order to co-locate the minima region of the artefact with the measurement electrode. For example the stimulus may be delivered in a tripolar fashion by three stimulus electrodes, comprising a central electrode which carries an entire stimulus current and two peripheral electrodes which carry two respective portions of the stimulus current to maintain charge-balanced stimulation, whereby the respective portions of the stimulus current carried by the peripheral stimulus electrodes are mismatched in a manner which causes the minima region of the artefact to be substantially co-located with the measurement electrode.
The desired ratio between the respective portions of the stimulus current carried by the peripheral electrodes, referred to herein as the stimulation ratio, differs depending on which measurement electrode(s) are in use. Accordingly, preferred embodiments provide an artefact minimisation algorithm which delivers a range of stimuli of varying stimulus ratio, at a sub-threshold level which does not recruit a neural response, and observes the artefact caused by each such stimulus at the measurement electrodes, in order to seek a stimulus ratio which minimises artefact observed upon the measurement electrodes in use.
Other embodiments of the first aspect of the invention may employ other stimulus configurations in order to cause the minima region of the artefact to be substantially co-located with the measurement electrode. For example, a quadrupolar stimulation configuration employing four stimulus electrodes, or a multipolar stimulation configuration employing more than four electrodes, may be employed, and may be preconfigured or adaptively configured to deliver stimulus ratio(s) which are mismatched in order to manipulate the location of the minima region of the artefact so that it is substantially co-located with the measurement electrode.
According to a third aspect the present invention provides an implantable lead for neurostimulation, the lead comprising a plurality of electrodes, each electrode having an electrode length and an electrode width, and the electrodes being longitudinally spaced apart by an inter-electrode spacing,
wherein the electrode width is greater than the electrode length;
wherein the electrode length is less than 3 mm, and
wherein a ratio of the inter-electrode spacing to the electrode length is between 2 and 3.66.
In embodiments of the third aspect, where the lead is a percutaneous lead comprising cuff electrodes passing substantially or wholly around a circumference of the lead, or in the case of non-cylindrical leads around a cross-sectional perimeter of the lead, the electrode width is defined herein as being equal to a width or diameter or largest cross-sectional dimension of the lead.
In embodiments of the third aspect, the electrode length is preferably greater than 1.5 mm, for example greater than 1.6 mm, more preferably greater than 1.8 mm. The electrode length is preferably less than 2.9 mm, more preferably less than 2.55 mm, more preferably less than 2.2 mm. The electrode length is preferably 2.0 mm.
In embodiments of the third aspect, the ratio of the inter-electrode spacing to the electrode length is preferably greater than 2.1, for example being greater than 2.25, more preferably greater than 2.4. The ratio of the inter-electrode spacing to the electrode length is preferably less than 3.5, for example being less than 3.1, more preferably being less than 2.7.
The ratio of the inter-electrode spacing to the electrode length is preferably 2.5.
According to a fourth aspect, the present invention provides a neurostimulation device comprising:
at least one stimulation electrode configured to deliver an electrical stimulus to neural tissue;
at least one measurement electrode configured to record a response of the neural tissue to the stimulus;
at least one passive electrode proximal to the measurement electrode; and
an impedance connected to the passive electrode, the impedance being configured to reduce artefact arising on the measurement electrode.
According to a fifth aspect, the present invention provides a method for neurostimulation, the method comprising:
delivering an electrical stimulus to neural tissue using at least one stimulation electrode; recording a response of the neural tissue to the stimulus using a measurement electrode; configuring an impedance connected to a passive electrode proximal to the measurement electrode, to reduce artefact arising on the measurement electrode.
In embodiments of the fourth and fifth aspects of the invention, the impedance may be preconfigured, and fixed. In alternative embodiments, the impedance may be a variable impedance, and may be adaptively configured by any suitable means in order to reduce, or preferably seek a minima in, artefact observed on the measurement electrode(s). For example the variable impedance may be adaptively configured by use of an artefact minimisation algorithm which delivers a range of stimuli while adjusting the variable impedance to take a range of distinct values, the stimuli being at a sub-threshold level which does not recruit a neural response, and observes the artefact caused by each such stimulus at the measurement electrode(s), in order to seek an impedance value which minimises artefact observed upon the measurement electrode(s) in use at the time. Alternatively, this technique may adopt the use of supra-threshold stimuli which do recruit neural responses, and may measure the total energy of the neural response+artefact, and may adjust the variable impedance in such a way as to seek a reduction or minima of such energy. The artefact minimisation algorithm of such embodiments may operate simultaneously with the above-described artefact minimisation algorithm of some embodiments of the first and second aspects of the invention, for example by use of two simultaneously or contemporaneously running feedback loops.
The impedance may comprise a resistance, or a reactance. The impedance may be variable by being implemented in the form of a switched capacitor resistance, configured to present a controllable resistance as defined electronically by a switching rate or pulse width modulation of the switched capacitor.
In some embodiments, the impedance is connected between a pair of passive electrodes positioned either side of the measurement electrode. In such embodiments, where more than one measurement electrode is used, one of the passive electrodes is preferably positioned between the measurement electrodes, and the other of the passive electrodes is preferably positioned between the stimulus electrode(s) and the measurement electrodes. Thereby, a pair of electrodes not involved in the stimulation or measurement can be used to steer a minima or zero of artefact onto a measurement electrode.
According to a sixth aspect, the present invention provides a neurostimulation device comprising:
at least one stimulation electrode configured to deliver an electrical stimulus to neural tissue; and
at least one measurement electrode configured to record a response of the neural tissue to the stimulus;
wherein the electrodes are arranged in a longitudinal array and at least one of the electrodes is configured to exhibit a greater resistance in a longitudinal direction as compared to a resistance of that electrode in a transverse direction.
In some embodiments of the sixth aspect, an electrode may be configured to exhibit a greater resistance in a longitudinal direction by providing the electrode with transverse slots or ribs, configured to increase a longitudinal current path length.
According to a seventh aspect, the present invention provides a neurostimulation device comprising:
at least one stimulation electrode configured to deliver an electrical stimulus to neural tissue;
a current source configured to produce the electrical stimulus; and
at least one measurement electrode configured to record a response of the neural tissue to the stimulus;
wherein the stimulation electrode is split into at least two electrode portions configured to create a discontinuity in a tissue-electrode interface, and wherein the current source is connected to the electrode portions by respective resistors.
In some embodiments of the seventh aspect, a first resistance connecting the current source to a first portion of the split electrode is different from a second resistance connecting the current source to a second portion of the split electrode. The first and second resistances are preferably selected, or are adaptively controlled, in a manner to counteract asymmetric voltages upon an electrode-tissue interface.
An example of the invention will now be described with reference to the accompanying drawings, in which:
Delivery of an appropriate stimulus to the nerve 180 evokes a neural response comprising a compound action potential which will propagate along the nerve 180 as illustrated, for therapeutic purposes which in the case of a spinal cord stimulator for chronic pain might be to create paraesthesia at a desired location. To this end the stimulus electrodes are used to deliver stimuli at any therapeutically suitable frequency, for example 30 Hz, although other frequencies may be used including as high as the kHz range, and/or stimuli may be delivered in a non-periodic manner such as in bursts, or sporadically, as appropriate for the patient. To fit the device, a clinician applies stimuli of various configurations which seek to produce a sensation that is experienced by the user as a paraesthesia. When a stimulus configuration is found which evokes paraesthesia, which is in a location and of a size which is congruent with the area of the user's body affected by pain, the clinician nominates that configuration for ongoing use.
The device 100 is further configured to sense the existence and intensity of compound action potentials (CAPs) propagating along nerve 180, whether such CAPs are evoked by the stimulus from electrodes 2 and 4, or otherwise evoked. To this end, any electrodes of the array 150 may be selected by the electrode selection module 126 to serve as measurement electrode 6 and measurement reference electrode 8. Signals sensed by the measurement electrodes 6 and 8 are passed to measurement circuitry 128, which for example may operate in accordance with the teachings of International Patent Application Publication No. WO2012155183 by the present applicant, the content of which is incorporated herein by reference. Nevertheless, artefact remains a significant obstacle to measurement of neural responses proximal to the stimulus location. The present disclosure first investigates the artefact phenomenon in more detail, and then provides a number of novel solutions based on the findings.
The current pulses delivered through platinum electrodes by medical implants to recruit neurones give rise to slowly-decaying voltage tails, called “artefact”. These tails make measurement of evoked potentials following the pulses very difficult. We present evidence to show that in a typical clinical scenario these tails are mostly caused by concentration gradients of species induced in the electrical double layer adsorbed onto the platinum surface of both stimulating and passive electrodes. A compact model is presented that allows simulation of these artefacts. This model can be expected to prove useful in predicting the effectiveness of techniques to reduce the artefact amplitude.
Considerable interest has arisen recently in sensing neural activity in the presence of, and quickly following, neural stimulus pulses in order to apply feedback in neuromodulation systems. The evoked compound action potentials (ECAP) synchronised with the stimulus and measured near the stimulation site betray the extent of neural recruitment resulting from the pulse. Measured ECAP thus can be of great assistance both during the implantation surgery and for automatic adjustment of the stimulus pulse amplitude and locale in routine use.
A typical neuromodulation pulse has an amplitude of several volts, whereas the amplitude of the signal visible at an electrode as a result of a nerve firing may be only a few microvolts. To be useful, the evoked responses must be recorded starting within about a hundred microseconds of the end of the stimulus pulse. To make the job of the recording electronics even more difficult, the artefact tails have amplitudes between millivolts and tens of microvolts depending upon the spacing between the stimulus and recording electrodes. Sensor electrodes which are closest to the stimulation site are best positioned to assess recruitment, but have greater artefact, as ECAP disperses as it propagates from the recruitment site. It is demanding to design amplifiers capable of processing these signals for analog-to-digital conversion, particularly in CMOS.
In this light, a compact model of the impedance of the electrode-electrolyte interface is presented. This model uses Constant-Phase Elements (CPEs) amongst other more common elements in an equivalent-circuit representation of the interface between electrode and electrolyte. The model is able to accurately represent the impedance of the interface. In a circuit simulator the model allows prediction of the residual voltage and artefact tails in some circumstances, but not all. As will be seen below, the model predicts zero artefact in certain circuit configurations, whereas measurement reveals that significant artefact actually arises in such configurations. This makes clear that there is a mechanism at work that is not captured by the single-CPE compact model.
Accordingly, the present inventors introduce a split-electrode model. It has been hypothesized that artefact can arise not only through residual charge left in the double layer surrounding an electrode after it conducts a current, but also by virtue of an uneven distribution of that charge along the surface of an electrode. Such an uneven charge distribution can arise even without any net current flowing through the electrode into the electronics. One might visualise counter-charges in the diffuse region of the electrical double layer piling up at one end of an electrode as a result of surface conduction, resulting from fields generated by the stimulating electrodes. Although for many purposes a more elaborate model is necessary, this idea of charges piling up at one end of an electrode suggests a straightforward way that a compact model might be constructed to simulate the phenomenon.
In the proposed split-electrode model, the electrode is split into multiple sections or “slices” that are modelled separately. The single-branch model of an electrode is replaced with one having n branches, each contributing 1/n times the total admittance (area) presented by the original electrode. The branches are joined together at a single node at the metal side of the electrode, but are connected only through the resistor mesh representing the bulk fluid on the fluid side of the interface (as shown in
A rotationally-symmetric situation is considered, so that simulation is straightforward using a two-dimensional representation, and comparative measurements can be made with a cylindrical, implantable, platinum electrode array such as an octrode (eight electrode array) or dodecatrode (twelve electrode array). A typical implantable lead electrode array with a set of 8 electrodes (cylindrical platinum cuffs), suitable for use as array 150 in the embodiment of
The equivalent circuit of a single cuff, omitting the diodes and memristors for clarity, is shown in
Resistor mesh values were calculated using a measured value of saline conductivity of 6400 mm and on a grid selected to suit the split factor. In this description we will chiefly consider one particular circuit arrangement, as depicted pictorially in
This configuration was simulated using a single-CPE model for the electrodes in 0.1x Phosphate Buffered Saline (PBS). In the case of a single-branch electrode model, absolutely zero artefact is predicted to appear between electrodes 4 and 7, assuming there is no load presented by the electronics. However, when the electrode model is split into ever-greater numbers of slices, the prediction changes.
Comparison with measurement was performed. A Saluda Medical Pty Ltd “Evoke” implant was used to generate pulses and amplify the measured signals. The wiring arrangement is depicted pictorially in
It proves difficult to obtain agreement between simulation and measurement of artefact such as that observed at 820 in
A first such artefact component is artefact from passive electrodes. All the electrodes on a lead are exposed to a voltage gradient along their length during the pulse. Charge accumulates at one end of each conductive cuff compared to the other. There is generated a voltage gradient in the tissue or electrolyte in which the lead is immersed by the dipole of the stimulating and return electrodes, being electrodes 2 and 1 in this example. Charge is more easily displaced along the surface of the cuff than the surrounding medium. Once the pulse is over, even an electrode that was not electrically connected, and which conducted zero net current, acquires a charge imbalance along its surface that manifests itself as a transient net potential difference between the metal of the cuff and the bulk medium.
The same mechanism operates on electrode 7, but less than 2μV results, as compared to the net 100 μV on electrode 4. Thus, a total of 100 μV contribution is made to V(4,7), being the sensed voltage, chiefly because of the net voltage between the tissue side and the metallic side of electrode 4. The first artefact component, being artefact from passive electrodes, is thus a considerable contributor to the artefact problem.
A second artefact component is artefact from Stimulation Electrodes. The stimulating electrode, number 2 in our example, develops around 25 times the charge gradient along the length of its surface compared with electrode 4, since one end of it is much closer to the ground return path provided by the adjacent electrode 1.
The ground return electrode 1 responds in the same manner as the stimulating electrode 2, but the polarity of its contribution is the reverse, and it is a different distance from the receiving pair 4,7. The ground return electrode 1 thus also produces an artefact contribution to the measured voltage V(4,7). The difference between the contributions from the stimulating and ground electrodes is typically ≈50 μV, for a 5 mA stimulus. The second artefact component, being artefact from stimulation electrodes, is thus also a considerable contributor to the artefact problem.
A third artefact component is Common-Mode Artefact. The total charge accumulated across each of the stimulating and return electrodes between the metal and the medium (as different from the difference along the cuff purely on the electrolyte side) is many hundreds of mV, as seen in
Noting these components of artefact, it is possible to address the question of what total artefact is generated by these mechanisms when they are operating together.
A fourth artefact component is the contribution from a single passive cuff electrode. The impact of charges “passively displaced” by flowing stimulus currents is key to understanding, and cannot be underestimated. To emphasise this point and aid understanding, consider
The observation that this electrode model only predicts artefact at all when the electrode is modelled as a parallel series of “slices” that are free to accumulate unequal charges confirms the conjecture that uneven charge distribution on the surface of individual electrodes contributes to the long pulse tails referred to as “artefact” observed on implanted measurement electrodes. It is further noted that the model shows that surface charge imbalance is the main or possibly sole contributor to artefact, as
The preceding analysis thus provides confirmation of an electrode-intrinsic mechanism responsible for electrode artefact. By “electrode-intrinsic” we mean a phenomenon that is an inescapable physical consequence of the electrode design, inherent to the geometry and materials of the electrode, and independent of electrical action, connection, or loading of associated electronics. While electrical efforts to minimise artefact tails in neuromodulation systems arising from electrical action, connection, or loading of associated electronics are important and ongoing, it is clear that the artefact measured in the present description inescapably arises within the electrode-electrolyte system itself. Thus, even a perfect front end amplifier will encounter this signal.
Armed with the new understanding that surface charge equilibrium will set a lower (best case) limit on the artefact which will necessarily be added to (i.e. arise contemporaneously with, and obscure) an evoked compound action potential, it becomes possible and important to consider how electrodes might be designed to intrinsically minimise the phenomenon, and also to consider what electrical steps might be taken to accommodate or even beneficially exploit this electrode-intrinsic mechanism and the findings of the preceding analysis. The following solutions are proposed.
Specifically, we describe several techniques conceived on the basis of the findings of the preceding analysis. These techniques include tripolar stimulation, bridged electrodes, and changes to electrode size and shape, any or all of which may be implemented in accordance with embodiments of the present invention.
Referring again to
The first aspect of the present invention recognises that this change in sign of artefact with increasing displacement from the stimulation electrode suggests that there exists at least one location along the lead where the sum of the artefact components is zero. We therefore turn to consider ways in which the artefact may be minimized or substantially eliminated at the location of the measurement electrode, even if artefact is non-zero at locations away from the measurement electrode, by causing the location of a zero-crossing of artefact to be substantially co-located with a measurement electrode. We propose that this may be effected in one or more of a number of ways, including by means of changing the layout of electrodes, changing the interconnection of the electrodes, and/or changing the spatio-temporal distribution of stimulus current delivered.
The present embodiments recognise that artefact zero can be steered with careful tripolar stimulation. In particular, the present inventors recognise that the artefact zero can be displaced onto the 4th electrode by adding some contributory current to the 3rd electrode, so that the 2nd and 3rd electrodes combined provide the stimulus current that is returned via the 1st electrode. In general, the principle is to stimulate through three or more electrodes in some fashion, often utilising an asymmetric current division, in a manner that minimises artefact on another electrode or electrodes.
In saline, simulation predicts that there will be a zero of artefact on electrode 4 when stimulus current X flowing into electrode 1 is fed by yX out of electrode 2 and (1-y)X is fed out of electrode 3. Measurement puts these currents close to 0.5× and 0.5× respectively, y=0.5.
Tripolar stimulation is described herein by the general definition [X,x,A],[Y,y,−1],[Z,z,1-A] where X,Y,Z are contact numbers, x,y,z are the nodes to which each of the other ends of the current sources are connected. In this document in most cases x=y=z=0 as it can be simpler to explain the situation of current sources between electrodes. Usually X <Y <Z indicating that the electrodes numbers are sequential and A<1. If A=1 or A=0 this becomes bipolar stimulation.
Quadrupolar can be described by the notation [1,0,A,B],[2,0,A.(1-B)],[3,0,−1],[4,0,1-A] where 0<A<1 and 0<B<1. “A” describes the charge division between the electrodes E1 and E2, and E3, which are proximal and distal to E3, while B defines the distribution of charge between E1 and E2.
When A is equal to 0.7, and assuming the resistances of the electrodes are similar, the proportion of current in E1, E2 and E4 will be 35%, 35% and 30%. A similar effect would be expected when electrodes E1 E2 and E4 are simply connected together, which under the constant impedance approximation will result in division ratios of 33%, 33% and 33%. This is supported by clinical observations made by the present Applicant that in general “adding anodes reduces artefact”. As the respective electrode impedances may not be the same, it may be that using individual current sources on each electrode provides a more robust result. Simulations indicate that the artefact reaches a null with a current division set to 37.5%, 37.5%, and 25%, with the null appearing at a similar ratio on E5 to E6 (E5 is the first available recording electrode in quadrupolar stimulation; E4 in tripolar stimulation). This quadrupolar approach thus represents a further aspect of the invention. It will be appreciated that this multipolar method can be extended as long as the number of return electrodes is greater than 2. For example, a stimulation profile of [1,0,A/2],[2,0,A/2],[3,0,−1],[4,0,(1-A)/2],[4,0,(1-A)/2] would be expected to produce an artefact null while maintaining conditions for a single cathode on E3.
Another embodiment of the present invention is described as a variant of tripolar stimulation [X,0,A],[Y,0,−1],[Z,0,1-A] where X,Y and Z are any three electrodes, where Z is used as a recording electrode, 0<A<1. Thus, in this embodiment artefact is nulled by injecting a small amount of current into a recording electrode, whereby artefact can thus be titrated.
Another variant embodiment of tripolar stimulation may utilise automatic adjustment. In this embodiment the parameter A is adjusted automatically to minimize artefact, and it is embedded in a feedback loop to maintain an evoked response at a preset level. It is illustrated in
The detector for the artefact loop measures the total energy on the recording electrodes. This energy will include both ECAP and artefact. However, the distribution of current between the cathodes will not affect the ECAP as the current remains constant. However, this variation in distribution will affect the artefact. At the point where the artefact is zero, only the ECAP will remain. The artefact nulling feedback loop operates by first measuring the total energy of the signal. This is best done by measuring the standard deviation of the signal samples over the measurement time. Such a measure is immune to the DC offset in the signal, based on the definition of standard deviation. The artefact loop controller then adjusts the control parameter A. Initially, this change can be in either direction. The artefact loop controller then measures the total energy a second time, to determine if it has increased or decreased. The artefact loop controller then changes the value A in the direction that decreases the detected energy.
In another embodiment, the architecture of
Options for current division are shown in
As shown in
A further method is to use passive quadrupolar. Assuming equal tissue impedance on all return electrodes, this achieves a 33/33/33 current division ratio, although it is noted that this simplistic assumption ignores the unequal distance of the respective grounded return electrodes which will tend to cause unequal return current division ratio. Nevertheless passive quadrupolar is preferred compared to passive tripolar as it produces lower artefact due to this difference in current division. Passive quadrupolar does however require room on the lead for an additional stimulating electrode. An active quadrupolar division ratio of 37.5/37.5/25 has similar artefact characteristics to 75/25 tripolar. There are many variants on these methods depending on the exact patient circumstances. However, the principles have been illustrated and so it is to be appreciated that such other variants are within the scope of the present invention.
It is to be noted that some of the stimulation configurations presented in
A further approach to reducing artefact is that a pair of electrodes not involved in the stimulation or measurement can be used to steer a zero onto a measurement electrode, as shown in
In the example of
A third approach to artefact minimisation is to change the number, size and disposition of electrodes in a multi-electrode lead to minimize artefact on electrodes adjacent to stimulating electrodes.
Refer again to
A further solution offered by the present invention involves a revised electrode design that, in a preferred embodiment, reduces artefact by ⅓ compared to current state of the art electrode designs.
In
From this diagram it will be appreciated that if a voltage is applied between the right and left sides of the mesh, current will flow, and some will flow into the left-most CPE and then into the metallic electrode and this will then flow out of the right-most CPE. Current will also flow symmetrically, but to a lesser extent, through the centre two CPE elements. Consequently, at the end of some period, the voltage along the surface of the array, with respect to the metal, will be as shown in
Now consider a pair of adjacent stimulating electrodes shown in
Now consider a pair of adjacent recording electrodes shown in
This again illustrates the main mechanisms of artefact generation: a voltage along a recording electrode which is greater for electrodes closer to the stimulation source and a gradient on the stimulating electrode which is largest on the edges where the stimulating contacts are close to one another. Artefact then occurs as this charge redistributes during the recording period, creating a changing differential voltage between the recording electrode metal contacts. The above-described simulations have shown that these effects are of comparable magnitude.
These phenomena are caused by dipoles created on the stimulating and recording electrodes. A dipole creates an electrical moment proportional to size and distance between the opposing charges. Thus reducing the length of the dipole will reduce the field and thus the artefact. As the dipole is made unbalanced by the proximity of the stimulating electrodes (as in
These phenomena can be seen in simulations of this shortened electrode configuration. The simulation was performed using the methods described in the preceding.
The system implications of reducing electrode size include the following. The impedance of an electrode varies with its area, and thus its length. Reducing an electrode length from 3 mm to 2 mm increases its impedance (as simulated in a saline bath with 1/10 saline in tripolar mode) from 750 to 950 ohms. This will increase the power required to drive the electrode and thus reduce battery life. However, this trade-off is acceptable and can be recovered by other system design changes such as improved current delivery mechanisms as per Australian
Provisional Patent Application No. 2018900480, the content of which is incorporated by reference.
Another system implication pertains to safe charge. The maximum charge that can be delivered through an electrode before unsafe radicals (such as Cl and H) are generated depends on the electrode area. A 3 mm×1.3 mm electrode can be used to deliver 14.5 uC. Since most patients require a charge less than 7 uC to achieve comfort, and an electrode with a 2 mm length can deliver 9.7 uC before reaching its unsafe limit, an electrode length of 2 mm is thus more than adequate.
While
A further variant is illustrated in
Some embodiments of the invention may utilise 3D printing for construction of the device. Accordingly, in some embodiments the present invention may reside in a digital blueprint comprising a digital file in a format configured for use with rapid prototyping and computer aided design (CAD) and/or manufacturing, such as being in the STL (stereolithography) file format. Such digital blueprint files, whether produced by performing a three dimensional scan of an embodiment of the invention, or produced by a CAD development software tool, or the like, are within the scope of the present invention.
Some embodiments of the present invention may be implemented in conjunction with other techniques of artefact minimisation or remediation, including for example the use of a triphasic stimulation technique in accordance with the teachings of the present Applicant's International Patent Publication No. WO2017219096, the content of which is incorporated herein by reference.
It will be appreciated by persons skilled in the art that numerous variations and/or modifications may be made to the invention as shown in the specific embodiments without departing from the spirit or scope of the invention as broadly described. The present embodiments are, therefore, to be considered in all respects as illustrative and not limiting or restrictive.
Number | Date | Country | Kind |
---|---|---|---|
2018904012 | Oct 2018 | AU | national |
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/AU2019/051160 | 10/23/2019 | WO | 00 |